Efbemalenograstim alfa, CAS 2200269-79-8

Product Description: Efbemalenograstim alfa (F 627) is a recombinant fusion protein. Efbemalenograstim alfa is a long acting dimeric granulocyte colony-stimulating factor (G-CSF) that contains two human G-CSF fused to a human immunoglobulin G2 (hIgG2)-Fc fragment with a peptide linker. Efbemalenograstim alfa induces the production of white blood cells[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Daley W, et, al. Evive successfully concludes first phase III clinical trial of F-627 for chemotherapy-induced neutropenia and met primary endpoints. Shanghai, China: Evive Biotech; January 25, 2018.

CAS Number: 2200269-79-8

Molecular Weight: N/A

Compound Purity: 97.68

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99879-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99879-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated